Navigation Links
WaferGen Announces Second Quarter 2008 Financial Results
Date:8/13/2008

FREMONT, Calif., Aug. 13 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art gene expression, genotyping, cell biology and stem cell research systems, today highlighted the company's recent developments and milestones and announced financial results for the quarter and six months ended June 30, 2008.

Recent Corporate Developments and Milestones:

-- Initiation of alpha testing of WaferGen's SmartChip(TM) Real-Time PCR

System and proprietary oncology gene panel assays by the University of

Pittsburgh Medical School.

-- Close of private placement in the U.S. for a total of $3.6 million to

be used for general corporate purposes including the continued

advancement of the company's SmartChip(TM) Real-Time PCR System, as

well as the expansion of the company's global commercialization

campaign for its SmartSlide(TM) Micro-Incubation System.

-- Initial close of private placement by WaferGen's wholly owned Malaysian

subsidiary, WaferGen Biosystems (M) Sdn. Bhd to Malaysian Technology

Development Corporation Sdn. Bhd for a total of $1 million. An

additional $1 million is contingent on the subsidiary reaching certain

agreed upon milestones. Proceeds will be used to support the

high-volume manufacturing of the company's SmartChip(TM) Real-Time PCR

System in Malaysia.

-- Establishment of exclusive agreements for distribution of WaferGen's

SmartSlide(TM) Micro-Incubation System by leading distributors of

innovative products and services to cell biologists and stem cell

researchers in Switzerland, Taiwan, Germany and the Nordic Region

(Denmark, Sweden, Norway and Finland).

"During the second quarter of this year, we made significant progress in the development of our SmartChip Real-Time PCR System as evidenced by the in
'/>"/>

SOURCE WaferGen Biosystems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. WaferGen to Present at the Ninth Annual Beyond Genome Conference
2. WaferGen Announces Signing of Two Private Placements
3. WaferGen to Present at the Rodman and Renshaw Fifth Annual Global Healthcare Conference
4. WaferGen Signs Exclusive Distribution Agreement for SmartSlide(TM) Micro-Incubation System in Germany
5. WaferGen Signs Exclusive Distribution Agreement for SmartSlide(TM) Micro-Incubation System in United Kingdom and France
6. WaferGen to Present at the Cambridge Health Institutes Fifth Annual Molecular Diagnostics Partnerships in Personalized Medicine Conference
7. WaferGen Announces Management Team Promotions
8. WaferGen to Present at the Roth Capital Partners 20th Annual OC Growth Stock Conference
9. WaferGen to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
10. BioMS Medical Announces Second Quarter 2008 Results
11. Rosetta Genomics Announces Conference Call and Webcast of Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... , March 4, 2015 /CNW/ - Resverlogix ... it has completed a collaborative research program ... analytics.  Using Fast Collective Evolution Technology (FACET), ... including all measurements obtained from each of ... Phase 2 clinical trials ASSERT, SUSTAIN and ...
(Date:3/4/2015)... Proove Biosciences , a ... excited to announce the launch of their CME-accredited ... Management of Pain”. , The continuing medical education ... next year. The focus of the program is ... pain treatments, integrate appropriate pain management techniques, and ...
(Date:3/4/2015)... , March 4, 2015  BioClinica®, Inc., ... technology provider, today announced that clinical trial ... convened at its annual European User Conference ... to discuss the use of its eClinical ... eClinical technologies include: the Microsoft Office-Smart OnPoint ...
(Date:3/4/2015)... 2015 Follow us on LinkedIn ... the fastest growing technologies in the life sciences industry. ... is driving growth in nucleic acid detection technologies like ... gene expressions will continue to benefit the qPCR and ... ranging from pharma, biotech, food & beverage to animal ...
Breaking Biology Technology:Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 2Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 3Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 4Proove Biosciences Launches CME Accredited Program with Medscape 2Proove Biosciences Launches CME Accredited Program with Medscape 3BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 2Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 4
... LLC (L3I) has,successfully completed the Quality Management System (QMS) ... ISO 9001 and AS 9100,Certification under the rules of ... compliance and zero non-compliance issues. , ... Operations, Scott McAfee led,the creation, organization and refinement of ...
... Pharmaceuticals Inc.,is pleased to announce the appointment of Barry ... draw upon his 24 years of pharmaceutical sales and,marketing ... products for the company. , ... "We are extremely pleased to welcome Mr. ...
... 13 Johnston Blakely & Company, LLC, a,Boston-based ... that Michael,D. Webb has joined the firm as ... will,participate with the firm on internal and client-related ... equity placements, with a,particular focus on biopharmaceutical transactions. ...
Cached Biology Technology:Level 3 Inspection Achieves 100% Compliance in ISO 9001 & AS 9100 Certification 2
(Date:2/5/2015)... , Feb. 3, 2015 Despite ... demand from industries such as consumer electronics, automotive, ... for surface mount technology (SMT) screen printers. Innovations ... automatic control will push the adoption curve up. ... remain steady as glue dispensers are indispensable in ...
(Date:1/22/2015)... , Jan. 13, 2015  Today, FreeWavz ( www.FreeWavz.com ... its crowdfunding campaign on Fundable, https://www.fundable.com/freewavz . ... of production capacity to meet customer demand. ... - http://photos.prnewswire.com/prnh/20150113/168790 Invented ...
(Date:1/22/2015)... NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) a biometric authentication ... success of the Wocket™ smart wallet at CES 2015 in ... as one of the "11 Hot Products at CES" in a review ... So Far" by Newseveryday.com and "The top 10 gadgets from CES 2015" ...
Breaking Biology News(10 mins):End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3
... headed by Dr. Sara Melville at the University of ... African sleeping sickness has evolved an unusual chromosomal structure ... parasite, the chromosomes are highly enriched in subtelomeric sequences ... to the gene-rich cores. These subtelomeres, in some ...
... the Pacific Northwest Research Institute (PNRI) and the National ... pattern of DNA damage in connective tissues in the ... stages of breast cancer and possibly serve as an ... In the United States, breast cancer is the second ...
... years, researchers have struggled to understand how IVIG worked. ... bean apparent contradiction. , Intravenous immunoglobulin (IVIG) is ... plasma that contains the pooled antibodies from thousands of ... assorted conditions; nonetheless, practitioners have used it off-label with ...
Cached Biology News:DNA to the defense 2Links between DNA damage and breast cancer studied 2A single sugar found responsible for an antibody's ability to treat inflammation 2A single sugar found responsible for an antibody's ability to treat inflammation 3
DDO Immunogen: DDO (NP_003640, 270 a.a. ~ 370 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Yersinia pestis...
Insect Cell Lysis Buffer 50 ml...
Rabbit polyclonal to Orexin Prepro ( Abpromise for all tested applications). entrezGeneID: 3060 SwissProtID: O43612...
Biology Products: